Phenytek 200 mg/1 (Extended Phenytoin Sodium CAPSULE, EXTENDED RELEASE) 200 mg/1

Phenytek 200 mg/1 is an extended-release capsule used for managing certain types of seizures. This medication helps control electrical disturbances in the brain, promoting stability. Learn more about its uses and effects.

Strength

200 mg/1

Pack Size

30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0378-2670-93)

Manufacturer / TM Owner

Mylan Pharmaceuticals Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Phenytek 200 mg/1 is primarily used to manage seizures by stabilizing electrical activity in the brain. It is often prescribed for conditions like epilepsy, where controlling seizures is crucial. This extended-release formulation helps maintain consistent levels of the active ingredient, phenytoin sodium, in the body throughout the day.

Side Effects

Common effects of Phenytek 200 mg/1 may include dizziness, drowsiness, and coordination issues. Some users might experience nausea or vomiting. These effects can vary and are not exhaustive; always consult a healthcare provider for personalized advice.

Precautions & Warnings

Handle Phenytek 200 mg/1 with care, storing it at room temperature away from moisture and heat. Do not crush or chew the extended-release capsules, as this can affect their effectiveness. Keep out of reach of children and pets.

Avoid Interactions

Phenytek 200 mg/1 may interact with other medications, including certain antibiotics, antacids, and other seizure drugs. Alcohol can also affect its efficacy. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Phenytek 200 mg/1 is used to manage seizures by stabilizing electrical activity in the brain, often prescribed for conditions like epilepsy.

Take Phenytek 200 mg/1 orally, swallowing the extended-release capsule whole with water. Do not crush or chew the capsule.

Common side effects may include dizziness, drowsiness, and coordination issues. Some users might also experience nausea or vomiting.

Alcohol can interact with Phenytek 200 mg/1 and affect its efficacy. It is advisable to avoid alcohol while taking this medication.

Store Phenytek 200 mg/1 at room temperature, away from moisture and heat. Keep the capsules in their original container and out of reach of children and pets.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.